Companies similar to SONOMA BIO
Sign up to Download

1-30 of 7,008,842 results

  • sonomabio.com
  • 3
  • 2
  • 20
Founded by pioneers in T reg biology and cell therapy, we are employing proprietary platform technologies and approaches to develop a new generation of targeted and durable T reg cell therapies designed to cure autoimmune and inflammatory diseases.....
Relevance: 31.919842
  • med.stanford.edu
  • 24
  • 17
  • 141
The Stanford Multidisciplinary Cutaneous and T-cell Lymphoma team offers expert treatment for patients with cutaneous or systemic T-cell lymphomas, including mycosis fungoides (MF), Sézary syndrome (SS), CD30+ lymphoproliferative disorders..
Relevance: 21.065294
  • www.t-knife.com
  • 3
  • 3
  • 12
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer... We are focused on T cell receptor engineered T cell therapies, TCR-Ts, a promising modality that holds the potential to generate..
Relevance: 20.965946
  • artaxbiopharma.com
  • 1
  • 20
Artax Biopharma is developing first-in-class, oral small molecules that inhibit Nck binding to the TCR. Through this novel mechanism, Artax's Nck inhibitors selectively modulate Nck's amplification of the TCR, resulting in a lower T Cell activation..
Relevance: 20.939
  • cytoart.com
  • 2
  • 1
Cytoart is a biotechnology company aimed at improving the development, quality control and clinical monitoring of CAR T-cell therapies. By offering our comprehensive anti-idiotypic platform, we are a leading provider of companion diagnostics for CAR..
Relevance: 20.9388
  • medisixtx.com
  • 9
Visionary scientist and creator of the first anti-CD19 CAR, Professor Dario Campana established MediSix Therapeutics in 2016 to help patients with complex and rare T-cell malignancies... We believe that T-cell therapies will radically change the..
Relevance: 20.796309
  • www.tspotcovid.com
A leading global diagnostics company with a nearly 20-year history of transforming T cell science into meaningful insights using the T-SPOT Technology. The T-SPOT Technology is proven in TB diagnostics with > 20 million tests shipped to > 50..
Relevance: 20.697742
  • www.dynamiccelltherapies.com
  • 1
  • 1
Dynamic Cell Therapies is developing controllable CAR T cells to address difficult-to-treat cancers. Our platform technology of dynamic control of engineered T cells will improve the safety, efficacy, and durability of CAR T cell therapies. This..
Relevance: 20.204636
  • genomefrontier.com
  • 1
  • 1
  • 5
Using the Quantum Engine™, GenomeFrontier is developing multiple cell modified gene therapy products, including chimeric antigen receptor T (CAR-T) and T cell receptor T (TCR-T) therapies. These are live, cell-based "drugs" composed of immune cells..
Relevance: 20.183071
  • www.immuno-t.co.uk
  • 1
  • 1
The Immuno-T test was developed by the experts in T cell immunology. The team at ImmunoServ have specialised in T cell immunology research and development for decades... T cells are a critical component of your immunity to COVID-19. Monitor your T..
Relevance: 20.095806
  • wugen.com
  • 2
  • 23
Our cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute..
Relevance: 19.82188
  • kyvernatx.com
  • 7
  • 1
  • 19
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases... Kyverna is pioneering CAR T-cell therapies for autoimmune disease patients by harnessing..
Relevance: 19.76935
  • www.financeat.net
  • 2
  • 3
Finance A&T is a Financial Service and Consultancy Firm. Established October 16, 2009 with the Netherland Chambers of Commerce (Kamer van Koophandel) with Reg No:34361474... Established October 16, 2009 with the Netherland Chambers of Commerce..
Relevance: 19.73873
  • herlinglab.com
  • 1
  • 3
  • 2
Our laboratory focuses on targetable molecular events of malignant lymphocyte transformation and evaluation of such pathway dependence, with particular interest in the pathogenetic mechanisms of chronic lymphoid leukemias. These comprise a..
Relevance: 19.72975
  • tcbiopharm.com
  • 4
  • 1
  • 7
TC BioPharm (TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious..
Relevance: 19.70272
  • www.allprepaidplans.com
There are only 4 major cell phone networks in the United States: AT&T, T-Mobile, Sprint, and Verizon... Use the tabs to discover cell phone providers based on the network they operate on... A reference guide to prepaid wireless cell phone providers..
Relevance: 19.682701
  • allogene.com
  • 4
  • 2
  • 27
Allogene is developing allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapy to find the next immunologic breakthrough in cancer. That's how we're leading today, creating tomorrow... Our mission is to create and lead the next revolution..
Relevance: 19.6408
  • www.4immunetx.com
  • 3
  • 1
  • 9
4immune is a privately held biotechnology company located just outside Boston, Massachusetts focused on developing innovative, curative therapies for T cell-mediated autoimmune disorders... 4immune's platform technology addresses a broad range of T..
Relevance: 19.633144
  • www.for2799.de
  • 9
  • 2
  • 2
Current research on γδ T cells and their γδ TCR focusses on the identification of potential ligands for the γδ TCR, the role of γδ T cells in the control of infectious diseases, and the potential of γδ T cells for novel therapies against tumors...
Relevance: 19.411366
  • jabious.com
  • 1
  • 2
JA Bio is a startup bio-tech company located at Cambridge in Massachusetts. We are focusing on anti-cancer cell immune therapeutics discovery and development. Our research includes,... Based on NBRL (nbrm.org) developed immune cell therapy, JA Bio..
Relevance: 19.291674
  • triumvira.com
  • 1
  • 6
  • 12
Triumvira is developing unique, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat a broad range of patients with cancer... Our partners have independently validated our technology in..
Relevance: 19.25318
  • irvine-lab.mit.edu
  • 21
  • 3
  • 18
Engineering approaches grounded in immunology hold the key to the discovery and development of novel treatments for cancer, infectious disease, and autoimmunity. To this end, the overarching goal of our laboratory is to engineer immunity through a..
Relevance: 19.24677
  • verismotherapeutics.com
  • 2
  • 13
Verismo Therapeutics is pioneering CAR T-cell therapy for the treatment of solid tumors. This paradigm-shifting technology features a unique KIR-CAR construct that has been proven to reduce T-cell exhaustion and kill solid tumor models in in vivo..
Relevance: 19.20374
  • www.cyteph.bio
  • 2
  • 1
  • 6
Cyteph is an Australian biotechnology company developing off-the-shelf T cell and CAR T cell therapies, harnessing the power of the immune system to target and destroy solid tumours... Cyteph is a spin-out company from QIMR Berghofer Medical..
Relevance: 18.944263
  • budgetcellphonesalesandrepair.com
  • 1
At Budget Cell Phones, we make it easy for you to buy premium pre owned cell phone devices. Our knowledgeable staff can help you find the best deals on our used cell phones and accessories. We also carry a wide range of cell phone accessories,..
Relevance: 18.763802
  • www.immfinitybiotechnologies.com
Biotechnology to accelerate Therapeutic T-cell receptors..
Relevance: 18.664406
  • mynanostilbene.com
NanoStilbene Clinical Trial - These results suggest that NanoStilbene may be a useful adjuvant to immunotherapy of cancer rescuing T cell and NK cell activities...
Relevance: 18.662771
  • tdrdna.com
  • 1
Co-led design of chimeric antigen receptor T cell (UltraCAR-T®) therapy product development strategy, including invention, acquisition, and optimization of systems required for scalable decentralization of autologous GM-T Cell production (2012-19).....
Relevance: 18.632778
  • www.aurora-biopharma.com
  • 1
  • 2
  • 13
Aurora Biopharma is founded on a single mission to revolutionize the treatment of cancer, by using the human body's immune system. Aurora is developing state-of-the-art cancer immunotherapy, a form of adoptive cell transfer called Chimeric Antigen..
Relevance: 18.615477
  • chinacartcell.com
  • 3
  • 1
Albert on The cost of CAR-T preparation in China is much cheaper than in the USA... CAR-T cell therapy or Chimeric antigen receptorTcell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing..
Relevance: 18.575455